Skip to main content
. 2020 Dec 14;28:68. doi: 10.1186/s12998-020-00356-z

Table 2.

Effect of Clinical and Demographic Factors on Allowed Amount Per Patient Per Episode

Factor/Exposure Group/Referent (exp)
Allowed Amount
95% CI p-value Mean Amounts
Group/Referent
95% CI (Mean Amounts)
Group/Referent)
Intercept 237 231.8–242.3 p < .001
Cohort CoE/Network 0.77 0.75–0.79 p < .001 $252/$326 ($246 - $258)/($323 - $330)
Health Plan Commercial/Gov’t 1.49 1.47–1.52 p < .001 $350/ $235 ($345 - $355)/ ($230 - $239)
Region Urban/Rural 1.23 1.21–1.25 p < .001 $318/$259 ($313–$322)/($254 - $264)
Sex Female/Male 1.04 1.02–1.05 p < .001 $292/$282 ($287–$296)/($277–$286)

Note. Dependent Variable = Allowed Amount (positive expenditures modeled; N = 24,330). Exposure variables in this model include: Cohort, Health Plan, Region, and Sex (entered as factors in the GLM). maximum likelihood estimate

Exposure of interest/reference group (variable). Reference (or comparison) group is specified after the forward slash “/”

Mean (allowed) amounts presented for Group/Referent and 95% CIs (for mean allowed amounts) come from the GLM

model’s estimated mean